Please assess the completion status of the following clinical trial:

Trial Title: Studying Changes in Physical Function Measures in Stem Cell Transplant Patients at Risk for Steroid Myopathy

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Participants are willing and able to give written informed consent and to comply with all of the study visits and procedures~* Age \>= 55 years, or with a Sorror co-morbidity index of \>= 3~* Post allogenic hematopoietic stem cell transplantation using bone marrow, peripheral blood or cord blood; or after pre planned donor lymphocyte infusion~* Presumptive diagnosis of acute GVHD necessitating high-dose corticosteroid treatment (with an approximate starting dose of methylprednisolone equivalent of 2 mg/kg/day)~* Within 5 days of receiving corticosteroid treatment~* ECOG (Eastern Cooperative Oncology Group) performance status of 0, 1, or 2 or equivalent Karnofsky score of 60 or higher~* The patient is referred to the study by their stem cell transplant attending physician~Exclusion Criteria:~* Non-English speaking~* Underlying unstable cardiac or pulmonary disease in the opinion of the investigator that limits participant involvement in exercise~* Has a pre-transplant echocardiogram with ejection fraction \< 45%~* Requires supplemental oxygen to maintain oxygen (O2) saturation \> 92%~* Musculoskeletal injury that precludes participation in an exercise program~* Inability to participate in a structured exercise program~* Patients for whom the physician feels is unsafe for an exercise program~* Platelets equal to or less than 10,000 or evidence of active bleeding~* Patients who are unable to understand or follow through with the exercise program

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Supportive care (exercise intervention) (Type: EXPERIMENTAL): Patients complete a physical function test over 15 minutes at baseline, and at days 14, 28, and 56. Patients also participate in an 8-week home-based strengthening and walking program consisting of a strengthening/resistance program for 30 minutes, 3 times a week, and walking program for 20-30 minutes at least 3 times a week.

Based on this trial design, predict the completion outcome and termination type (if applicable).